Opportunity Information: Apply for PAR 18 552

The Partnership for Aging and Cancer Research (U01 - Clinical Trial Not Allowed) funding opportunity (PAR-18-552) is a National Institutes of Health (NIH) cooperative agreement designed to push forward research on how aging-related biological mechanisms influence cancer. The core aim is to deepen scientific understanding of the processes that mediate aging in the context of cancer, meaning applicants are expected to focus on the biology at the intersection of aging and cancer development, progression, or related mechanisms, rather than proposing clinical trials. Because this is a U01 mechanism, the award is structured as a cooperative agreement, which generally indicates a more active programmatic role for NIH staff compared with a standard research project grant, and it also signals that the work is expected to be collaborative, coordinated, and aligned with NIH priorities in this space.

A defining requirement of this opportunity is that the proposed project must be a true collaboration between a non-NIH Principal Investigator (the external, applicant-side PI) and an intramural NIH investigator specifically from the National Cancer Institute (NCI) and/or the National Institute on Aging (NIA), with the intramural investigator participating as a co-investigator. In practical terms, this means an eligible external organization submits the application, but the scientific plan needs to be jointly built with an intramural NCI/NIA partner, and the partnership itself is central to responsiveness. The intended outcome is to leverage complementary strengths: for example, specialized intramural expertise, unique resources, or platforms at NCI/NIA paired with external innovation, models, datasets, or domain expertise in aging biology or oncology.

The announcement is explicitly not intended to support clinical trials, as reflected in the title and “Clinical Trial Not Allowed” designation. Projects should therefore be framed as mechanistic or otherwise non-trial research that advances knowledge about aging-related pathways and their role in cancer. While the notice does not list specific scientific topics in the excerpt provided, the emphasis on “mechanisms mediating aging in cancer” points to studies that can clarify causal biology and underlying processes rather than purely descriptive or intervention-testing work in human trial settings.

Eligibility is broad and includes a wide range of U.S. public and private entities. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education when specified); for-profit organizations other than small businesses; and small businesses. In addition, the opportunity explicitly highlights that a variety of mission- and community-focused institutions and organizations are eligible, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and even non-U.S. (foreign) entities. Taken together, this signals an intent to encourage participation from diverse institutional types and geographies, as long as the required collaboration with intramural NCI and/or NIA investigators is in place.

From an administrative standpoint, the opportunity sits under the NIH with activity areas in education and health, and it is associated with CFDA numbers 93.396 and 93.866. The source data lists an award ceiling of $75,000, which suggests relatively limited direct costs per award or per year (depending on how the FOA structured budget periods), and applicants would need to shape a scope of work that is realistic within that constraint while still being scientifically meaningful. The original closing date shown is June 8, 2018, and the FOA creation date is December 22, 2017, which indicates this particular listing reflects a past application cycle; anyone considering it now would need to confirm whether the opportunity has been reissued, extended, or replaced by a newer FOA.

Overall, this grant opportunity is best understood as a targeted NIH partnership mechanism meant to catalyze collaborative, mechanistic aging-and-cancer research that bridges external research teams with intramural expertise at NCI and/or NIA, while excluding clinical trial activities and welcoming a very broad range of applicant organization types, including institutions serving underrepresented communities and foreign organizations.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Partnership for Aging and Cancer Research (U01 - Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.396, 93.866.
  • This funding opportunity was created on 2017-12-22.
  • Applicants must submit their applications by 2018-06-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Each selected applicant is eligible to receive up to $75,000.00 in funding.
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 552

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: USAID/DRC Broad Agency Announcement: Establishing Conflict Free Supply Chains in Eastern DRC and Reducing the Vulnerability of Artisanal and Small-Scale Mining Communities to Conflict

Previous opportunity: Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 552

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 552) also looked into and applied for these:

Funding Opportunity
Limited Competition: Data Analysis and Coordination Center for the MACS/WIHS Combined Cohort Study, MACS/WIHS-CCS (U01 Clinical Trials Not Allowed) Apply for RFA HL 19 007

Funding Number: RFA HL 19 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Apply for PAR 18 559

Funding Number: PAR 18 559
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required) Apply for PAR 18 560

Funding Number: PAR 18 560
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional) Apply for PAR 18 437

Funding Number: PAR 18 437
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
International Research Collaboration on Drug Abuse and Addiction Research (R01, Clinical Trial Optional) Apply for PA 18 568

Funding Number: PA 18 568
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01, Clinical Trial Optional) Apply for PA 18 569

Funding Number: PA 18 569
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01 Clinical Trial Optional) Apply for PA 18 603

Funding Number: PA 18 603
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Apply for PAR 18 605

Funding Number: PAR 18 605
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03 Clinical Trial Optional) Apply for PA 18 601

Funding Number: PA 18 601
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $50,000
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21 Clinical Trial Optional) Apply for PA 18 602

Funding Number: PA 18 602
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Apply for PAR 18 606

Funding Number: PAR 18 606
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Training Modules to Enhance the Rigor and Reproducibility of Biomedical Research (R25 Clinical Trial Not Allowed) Apply for RFA GM 18 002

Funding Number: RFA GM 18 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 Clinical Trial Optional) Apply for PAR 18 612

Funding Number: PAR 18 612
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 Clinical Trial Optional) Apply for PAR 18 611

Funding Number: PAR 18 611
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional) Apply for PAS 18 624

Funding Number: PAS 18 624
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional) Apply for PAS 18 625

Funding Number: PAS 18 625
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
NIDA Small Research Grant Program (R03 Clinical Trial Required) Apply for PA 18 626

Funding Number: PA 18 626
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $50,000
NIDA Academic Research Enhancement Award (R15, Clinical Trials Required) Apply for PA 18 627

Funding Number: PA 18 627
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Apply for PA 18 629

Funding Number: PA 18 629
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $499,999
NIDA Small Research Grant Program (R03 Clinical Trial Required) Apply for PA 18 634

Funding Number: PA 18 634
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $50,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 552", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: